ResMed
Financial Performance
ResMed Revenue & Financials
Revenue
$4.7B (FY2024)
Market Cap
$32B
Net Income
$1B
Employees
10,000
What is ResMed's revenue?
ResMed had $4.7B in revenue for fiscal year 2024, up 10.9% from 2023. Net income was $1B.
- Latest revenue
- $4.7B (FY2024)
- Year-over-year
- +10.9%
- Growth rate (CAGR)
- 12.1% over 9 years
- Peak revenue
- $4.7B (FY2024)
- Years of data
- 10
- Employees
- 10,000
- How much profit does ResMed make?
- ResMed reported net income of $1B for fiscal year 2024.
- How many employees does ResMed have?
- ResMed has about 10,000 employees.
Financial Analysis
ResMed demonstrates exceptional financial strength, high returns on invested capital, and robust compounding cash flow. In fiscal year 2024, ResMed generated consolidated net revenues of $4.68 billion, up 11% year-over-year. Operating income rose 17% to $1.41 billion, with GAAP net income surpassing $1.02 billion ($6.92 diluted EPS). ResMed generated $1.4 billion in operating cash flow and deployed $280 million in annual cash dividends while maintaining an ultra-clean balance sheet with net debt below 1.0x EBITDA.
Revenue Trend Analysis
YoY Change
+10.9%
9-Year CAGR
+12.1%
Peak Year
2024
Trend
Consistent Growth
ResMed has 10 full fiscal year figures on this page, compounding at +12.1% annually over 9 years. The most recent year saw a 10.9% increase versus the prior year. Annual revenue peaked in fiscal year 2024 at $4.7B. Of 9 comparable year-over-year steps, 9 showed growth and 0 showed a decline.
Annual revenue history
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $4.7B | $1B | +10.9% |
| FY2023 | $4.2B | $897.6M | +18.0% |
| FY2022 | $3.6B | $779.4M | +11.9% |
| FY2021 | $3.2B | $474.5M | +8.1% |
| FY2020 | $3B | $621.7M | +13.4% |
| FY2019 | $2.6B | $404.6M | +11.4% |
| FY2018 | $2.3B | $315.6M | +13.2% |
| FY2017 | $2.1B | $342.3M | +12.4% |
| FY2016 | $1.8B | $352.4M | +9.5% |
| FY2015 | $1.7B | $352.9M | — |
Click any row to see year details.
Keep researching ResMed
ResMed Revenue and Financial FAQ
What was ResMed's latest reported annual revenue?
In its latest audited financial reporting period, ResMed recorded consolidated net revenue of $4.68B, demonstrating durable revenue growth across its primary operating divisions.
How profitable is ResMed?
ResMed generates industry-leading profitability, combining disciplined cost management with high gross margins to deliver substantial net earnings and superior return on equity (ROE) throughout changing economic cycles.
What is ResMed's capital and liquidity position?
ResMed maintains a fortress balance sheet equipped with ample liquid cash reserves, conservative debt leverage, and capital adequacy ratios that provide substantial safety margins above statutory regulatory requirements.
Does ResMed distribute capital to shareholders?
ResMed executes a disciplined capital allocation strategy that balances internal reinvestment into digital innovation and strategic growth with sustainable ordinary dividends and accretive share repurchase programs.
Cite or embed this data
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "ResMed Revenue & Financials." CorpDigest, https://corpdigest.com/company/resmed/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>ResMed reported $4.7B in revenue (FY2024).</strong><br>Source: <a href="https://corpdigest.com/company/resmed/financials" target="_blank" rel="noopener">CorpDigest — ResMed financials</a></div>Related Financial Audits
Compare revenue, net income, and market cap scale
Explore ResMed
Core profile pages, founders and related research hubs for this company.